You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Turkey

Sep 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Turkey with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Turkey, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Turkey for free:

The Consumer Health in Turkey market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Turkey?
  • What are the major brands in Turkey?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health market records slight growth in 2010

After three years of negative growth, the consumer health market posted a small increase in current value in 2010. Growth returned in line with increasing purchasing power and a rebound in consumer spending confidence after the global economic crisis. NRT smoking cessation aids proved to be the best-performing category in terms of current value growth due to increasing pressures on the government to implement a smoking ban indoors. The key category of vitamins and dietary supplements struggled due to relatively high prices and the inability to reimburse costs.

Pharmaceuticals industry still awaits OTC legislation

In 2010, the debate surrounding the long-awaited OTC legislation began to heat up as the government announced further details regarding the proposed legislation, which is expected to bring about fundamental structural change in the pharmaceuticals industry. The legislation entails an expanded list of OTC products, which can be advertised and sold in supermarkets, still lacking reimbursement by the state social security system. Pharmacists’ and doctors’ associations strongly oppose the proposed changes as they continue to argue that all products related to health should be sold under the supervision of health professionals.

Multinational players continue to dominate competition

The top-performing companies in the Turkish consumer health market are international companies led by Sandoz and Roche. However, local companies dominate a number of categories, such as wound care, ear care, and cough and cold remedies. Local companies typically shape their strategic direction through licence agreements, and other forms of cooperation. Generic products help local players to realise higher profits. More multinational players are expected to enter the market through mergers, acquisitions or cooperation with existing local players.

Chemists/pharmacies continue to dominate consumer health distribution

In 2010, chemists/pharmacies maintained their position as the major distribution channel in the consumer health market. In Turkey, the pharmaceuticals market is heavily regulated and a large number small independent chemists/pharmacies dominate retail sales. Sales through the internet, retail chains such as GNC, and direct selling are permitted in a number of categories, including vitamins and dietary supplements, and weight management. The pharmacists’ association strongly opposes sales of herbal/traditional products outside chemists/pharmacies, forcing the Ministry of Health to ban the sale of such products through internet retailers.

Downturn in constant value growth expected over the forecast period

In its current state, the consumer health market is expected to show further decline over the forecast period, yet the structural changes brought by the upcoming OTC legislation are expected to open up lucrative avenues for companies.

Table of Contents

Table of Contents

Consumer Health in Turkey - Industry Overview

EXECUTIVE SUMMARY

Consumer health market records slight growth in 2010

Pharmaceuticals industry still awaits OTC legislation

Multinational players continue to dominate competition

Chemists/pharmacies continue to dominate consumer health distribution

Downturn in constant value growth expected over the forecast period

KEY TRENDS AND DEVELOPMENTS

Upcoming OTC legislation opens up new avenues for consumer health market

Increasing popularity of healthy living has mixed implications for consumer health market

Increasing popularity of phytotherapy and traditional/home-made remedies threatens consumer health market

Increasing sales of non-prescription products raise hopes for growth of the consumer health market

Domestic production of generic alternatives offers lucrative prospects for pharmaceutical firms

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 8 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 9 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

De-listing or de-reimbursement

Advertising

Packaging and labelling

Self-medication and preventative medicine

Generics

Consumer health registration and classification

Vitamins and dietary supplements registration and classification

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Turkey - Company Profiles

Abdi Ibrahim Ilaç Sanayi ve Ticaret AS in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Abdi Ibrahim Ilaç Sanayi ve Ticaret AS: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 6 Abdi Ibrahim Ilaç Sanayi ve Ticaret AS: Competitive Position 2010

Betasan AS in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 8 Betasan AS: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 9 Betasan: Competitive Position 2010

Bilim Ilac Sanayi ve Ticaret AS in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 12 Bilim Ilac Sanayi ve Ticaret AS: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 13 Bilim Ilac Sanayi ve Ticaret AS: Competitive Position 2010

Eczacibasi Ilac Pazarlama AS in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

COMPETITIVE POSITIONING

  • Summary 16 Eczacibasi Ilac Pazarlama AS: Competitive Position 2010

Kurtsan Ilaclari AS in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 18 Kurtsan Ilaclari AS: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 19 Kurtsan Ilaclari AS: Competitive Position 2010

Adult Mouth Care in Turkey - Category Analysis

HEADLINES

TRENDS

  • The exclusion of these products from the reimbursement list of the state social security system forces companies to compete on price. Products in this category remained free from government pressure for price discounts as they are not reimbursed, yet the price of second-ranked brand Biokadine Agiz Antiseptigi fell from TL6.00 to TL4.82 in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Dentinox by Abdi Ibrahim Ilaç Sanayi ve Ticaret AS has a leading market share of 37%. Dentinox owes its share to brand recognition and its multi-purpose attributes as it can be used to ease gum pain for babies’ growing teeth and adolescents having problems with their wisdom teeth. Biokadine Agiz Antiseptigi offers an even wider range of uses, as it also serves as a disinfectant for the skin.

PROSPECTS

  • Non-prescription sales of adult mouth care products are expected to decline by 15% in constant value terms over the forecast period, with pressure from prescription alternatives; however the rate of decline is expected to fall over the 5-year period. On the other hand, the introduction of the long-awaited OTC legislation could provide some momentum for the market, as more brands may switch to non-prescription status. As for existing brands, growth prospects are minimal over the forecast period.

CATEGORY DATA

  • Table 10 Sales of Adult Mouth Care: Value 2005-2010
  • Table 11 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 12 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 13 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 14 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 15 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Turkey - Category Analysis

HEADLINES

TRENDS

  • Sales of analgesics saw 1% growth in current value terms in 2010, to reach TL16 million. The only products available OTC are aspirin, ibuprofen and topical formats. Acetaminophen, combination products - analgesics, diclofenac, dipyrone and ketoprofen within adult analgesics, and all child-specific analgesics have no brands sold without prescription.

SWITCHES

COMPETITIVE LANDSCAPE

  • Atabay Ilac Fabrikalari Ltd Sti is the leading company with a solid 44% share of value sales, thanks to its Suprafen brand which leads the significant ibuprofen category. The brand enjoyed a slight increase in share in 2010 and is the brand most recommended by chemists/pharmacists to consumers asking for a non-prescription analgesic.

PROSPECTS

  • Analgesics is expected record a decline of 13% in constant value terms over the forecast period. The overall decline is due to pressures from prescription alternatives reimbursed by the state social security system.

CATEGORY DATA

  • Table 16 Sales of Analgesics by Category: Value 2005-2010
  • Table 17 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 18 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 19 Analgesics Company Shares by Value 2006-2010
  • Table 20 Analgesics Brand Shares by Value 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Turkey - Category Analysis

HEADLINES

TRENDS

  • Discounts forced by the state social security system, led to a decrease in prescription products challenging the position of non-prescription brands. As a result, OTC calming and sleeping sales were able to post current value growth of 4%, reaching TL60 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sandoz’s Passiflora Surup is the market leader with a value share consistently above 80% over the last five years. Sandoz took over Passiflora Surup from Ilsan Ilac SA which ceased its operations several years ago. As with all pharmaceutical products, advertising of calming and sleeping products is forbidden in Turkey, yet Passiflora achieves a high level of brand awareness among consumers as a non-addictive herbal solution to stress and mild sleeplessness.

PROSPECTS

  • As stress has become an inevitable consequence of modern urban life, and has been identified as a major source of many health problems the demand for calming and sleeping products is likely to grow over the forecast period. While the category is expected to suffer contraction in the first three years of the forecast period, the figures are expected to turn from negative to positive as proposed OTC legislation and new retail systems come into effect. The challenge from prescription products will continue as they are included in the reimbursement list of the state social security system. The Ministry of Health’s introduction of a new system to reduce reimbursement spending may brighten the prospects of this category, yet low-priced prescription alternatives will continue to steal OTC calming and sleeping sales.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 26 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2010, SGK introduced new fees associated with reimbursement of pharmaceuticals including a fixed cost for every prescription obtained by the health institution. This cost discouraged patients from obtaining their prescriptions written by doctors, especially for cheaper products and when only a few products are to be included in the prescription. Patients are now more willing to pay for such products especially when the symptoms are familiar and mild, and there is no mention of any epidemic in the media. This willingness of patients to pay for their own products increases the chances for non-prescription alternatives, especially those with lower prices yet still subject to competition from UTC sales of prescription products, particularly when cheaper generic alternatives are available.

SWITCHES

COMPETITIVE LANDSCAPE

  • The Boots Co Plc’s Strepsils was the top-performing brand in 2010, yet Kurtsan Ilaclari AS led the market with a higher total share thanks to its multiple products. Boots’ Strepsils and Kurtsan’s Otaci and Oka-Mentol compete for same end-user, yet Strepsils has become the market leader due to heavy promotion targeting doctors and chemists/pharmacists. While Kurtsan’s brands are regarded as herbal, thus natural alternatives, Strepsils is perceived more towards the medical end of the spectrum. Strepsils are mostly consumed in the winter, to relieve sore throats due to cold. Otaci and Oka-Mentol are mostly used to ease sore throats due to dryness.

PROSPECTS

  • Sales of cough, cold and allergy remedies are expected to decline further and faster over the forecast period losing a quarter of its value in constant terms by the end of 2015 due to pressures from UTC sales and reimbursed products. However, with the introduction of new OTC legislation the market’s fortunes may turn positive as UTC products are excluded from the reimbursement and included in the OTC list fuelling competition within this category.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Sales of Decongestants by Category: Value 2005-2010
  • Table 32 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 33 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 34 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 35 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 36 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Turkey - Category Analysis

HEADLINES

TRENDS

  • The decline in sales of digestive remedies is mostly due to the fact that the brands in this category are not reimbursed by the state social security system. Consumers’ purchasing power dictates the size of the market for non-reimbursement products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Liba Laboratuvari AS leads the market with a 36% value share as Laksafenol is the key laxative in the market to be sold without a prescription and accounts for 80% of laxatives value sales. Liba has seen the greatest increase in value sales despite the decrease in the size of the laxatives category.

PROSPECTS

  • Digestive remedies sales are expected to continue declining in the coming five years, with relatively high rates of decline in the first years of the forecast period. Unit prices are expected decline as a result of the pressures from generic alternatives as well as prescription drugs reimbursed by SGK. OTC legislation is still awaited by the industry, and many trade sources are reluctant to comment on forecasts due to the ambiguity caused by the absence of such legislation. The long-awaited OTC legislation will identify which brands will be sold without prescription. On the other hand, SGK constantly revises the list of products subject to reimbursement, as this list is also considered the backbone of the OTC products list.

CATEGORY DATA

  • Table 37 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 38 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 39 Digestive Remedies Company Shares by Value 2006-2010
  • Table 40 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 41 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 42 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Turkey - Category Analysis

HEADLINES

TRENDS

  • Due to heavy restrictions in the Turkish pharmaceuticals market there are very few brands sold OTC within ear care. The much-anticipated OTC legislation is expected to release some of these restrictions and allow several brands to be sold without prescription. This OTC legislation also proposes OTC products to be sold in supermarkets and drugstore chains.

SWITCHES

COMPETITIVE LANDSCAPE

  • Since Norsol is the only significant brand in this category, domestic company Bilim Ilac Sanayi ve Ticaret AS is the key player in the market. The relatively small size of the market discourages potential entrants as does Bilim’s strong presence, with 82% of value sales in 2010.

PROSPECTS

  • If the status quo persists, the ear care market is expected to face an even greater decline over the forecast period, exceeding 5% each year in constant value terms. However, should OTC status be granted to ear care products there will be switches to OTC as well as potential new entrants into the category.

CATEGORY DATA

  • Table 43 Sales of Ear Care: Value 2005-2010
  • Table 44 Sales of Ear Care: % Value Growth 2005-2010
  • Table 45 Ear Care Company Shares by Value 2006-2010
  • Table 46 Ear Care Brand Shares by Value 2007-2010
  • Table 47 Forecast Sales of Ear Care: Value 2010-2015
  • Table 48 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Turkey - Category Analysis

TRENDS

  • There are no sales of OTC eye care products in Turkey.

Herbal/Traditional Products in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2010, the Ministry of Health announced that all herbal/traditional products would be classified as drugs and therefore would be subject to controls. Such products will be sold exclusively in chemists/pharmacies, including vitamins and mineral supplements while dietary supplements and dermatological/cosmetic products are excluded. Moreover, an advanced level of proficiency in the chemistry, pharmacology or medicine fields is required to be able to obtain a licence for importing or manufacturing such products.

COMPETITIVE LANDSCAPE

  • Sandoz leads the market with three quarters of value sales, with Passiflora clearly the top brand in the category. Increasing occurrence of stress-related symptoms has established Passiflora as one of the most popular non-prescription brands.

PROSPECTS

  • The latest regulation regarding the category is expected to limit distribution to specialist retailers. Direct selling is expected to decline given that sales of vitamins through non-specialist retailing channels will be restricted; this is expected to cause a contraction in the market in the first couple of years of the forecast period, followed by a steady increase in overall market size thereafter.

CATEGORY DATA

  • Table 49 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 50 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 51 Herbal/Traditional Products Company Shares 2006-2010
  • Table 52 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 53 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 54 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Turkey - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care products are regarded more as cosmetics rather than medicines because of the problems they are intended to solve. These are usually the type of products consumers decide to buy themselves when self-medicating, rather than treatments for more severe dermatological problems such as eczema or allergies. Substitutes for this category are usually cosmetic products rather than medicines. Most of the products in this category are also available in supermarkets and cosmetics and toiletries retailers.

SWITCHES

COMPETITIVE LANDSCAPE

  • Avon is the leading company in this category with its Clearskin brand. Consumers have high awareness of the Avon brand as it is heavily marketed through advertising and direct marketing. Clearskin products are regarded as cosmetic products rather than medicated skin care, and the fact that they can be bought from a chemist/pharmacy is the principal reason behind the brand’s leading position in the category.

PROSPECTS

  • Medicated skin care sales are expected to decline over the forecast period with a negative CAGR of 2% in constant value terms due to heavy pressure from cosmetic substitutes. However, unlike other categories, many products in this category can be advertised via mass media allowing room for companies prepared to spend funds on marketing communications.

CATEGORY DATA

  • Table 55 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 56 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 57 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 58 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 59 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 60 Acne Treatments Brand Shares by Value 2007-2010
  • Table 61 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 62 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 63 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Turkey - Category Analysis

HEADLINES

TRENDS

  • The ban on smoking in public places implemented in 2009 has been strictly applied despite the protests from various parties such as restaurant and coffeehouse owners, yet the percentage of smokers within the total population remains unchanged. In 2010, the Ministry of Health announced that it plans to test a newly-imported smoking cessation drug, and if it proves to be successful, it will be sold via prescription with reimbursement from SGK. The Ministry of Health also introduced Alo 171, “Quit Smoking Hotline” in November 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • By the end of 2010, Novartis maintained its position as the market leader because of its first-mover advantage as well as brand recognition among users.

PROSPECTS

  • By the end of 2011, all tobacco products are expected to be sold under the counter without displays at retail points of sale. This is regarded as the next step in the government’s anti-smoking campaign, accompanied with the new NRT smoking cessation product to be reimbursed by SGK. However, this may have a negative impact on sales of NRT patches and NRT gum which are sold without prescription.

CATEGORY INDICATORS

  • Table 64 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 65 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 66 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 67 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 68 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 69 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 70 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 71 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2010, 6% in current value terms should be considered a realistic growth rate given the essentially small size of the market. The growth is attributed to increasing awareness among the public about the benefits of regular exercise for healthy living. However, the user base is still limited to professional athletes and fitness enthusiasts.

COMPETITIVE LANDSCAPE

  • GNC leads the sports nutrition market with a 49% value share, while a large number of small distributors constitute some 31% of the market. GNC’s widespread presence through its own retail points of sale, along with online sales has helped the company to establish itself as the key player. However, its absence from both dedicated online sports nutrition retailers and other online shopping sites poses a threat to its further growth.

PROSPECTS

  • Sports nutrition sales are expected to expand as more people are attracted by the fitness trend. Companies will try to anticipate emerging consumer needs by developing more relevant products for different groups, switching to segmentation based on function/benefit and gender.

CATEGORY DATA

  • Table 72 Table: Sports Nutrition, Category Rankings 2010
  • Table 73 Sales of Sports Nutrition: Value 2005-2010
  • Table 74 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 75 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 76 Sports Nutrition Company Shares 2006-2010
  • Table 77 Sports Nutrition Brand Shares 2007-2010
  • Table 78 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 79 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Turkey - Category Analysis

HEADLINES

TRENDS

  • In late 2010, the Ministry of Health initiated an action plan called “Healthy Nutrition and Mobile Life Programme/Fight Against Obesity 2010-2014”, including various activities to inform young Turks about the dangers related to obesity and demonstrate how to prevent obesity in children. This plan identifies malnutrition as one of the causes of obesity, stating that the consumption of fast food results in vitamin A and C deficiencies among children. The action plan aims to introduce the concept of “balanced nutrition” to children and adolescents, informing the potential food sources that contain the vitamins needed by children and adolescents across different age groups.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The VDS market is led by Roche with a 27% value share, Novartis and Amway holding second and third positions, respectively. Roche offers a wide variety of products including Supradyn, the leading brand in multivitamins. Calcium Sandoz by Novartis leads dietary supplements with a 31% value share, with the Sandoz umbrella brand holding around half of non-herbal dietary supplements value sales. The popular belief that Calcium Sandoz reinforces the immune system increases demand for this product during the winter season. The extension of the swine flu epidemic into the early months of 2010 helped Calcium Sandoz to protect its leading position in 2010. Solgar has shown healthy performance in increasing its share due to the introduction of new products.

PROSPECTS

  • VDS sales are expected to post a negative CAGR of 4% in constant value terms over the forecast period. Growth rates will be negative in constant value terms for both vitamins and dietary supplements, however there will be some bright spots; glucosamine, co-enzyme Q10, mineral supplements and vitamin B being the key growth areas.

CATEGORY DATA

  • Table 80 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 81 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 82 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 83 Dietary Supplements by Positioning 2005-2010
  • Table 84 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 85 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 86 Vitamins Brand Shares by Value 2007-2010
  • Table 87 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 88 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 89 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2010, a number of deaths linked to use of weight loss products aroused suspicion surrounding the entire slimming products market. The weight loss category is adversely affected by the seasonal fads of slimming products promising rapid and lasting results. Due to their herbal content, slimming pills are not classified as pharmaceutical products, thereby escaping the authority of the Ministry of Health. Following these unfortunate incidents, the Ministry of Health claimed no responsibility stating that only one brand is actually licenced through the Ministry of Health, and sold via prescription. The Ministry of Health also made an appeal to assume full control of all herbal/traditional products, which were previously controlled by the Ministry of Agriculture.

COMPETITIVE LANDSCAPE

  • Herbalife is the leading company in weight management, owing its position to the Formula 1 brand. The direct selling model and word-of-mouth recommendation regarding the ability of its products to provide successful results have helped Herbalife to establish a solid consumer base.

PROSPECTS

  • Despite the expected decline over the forecast period, the entrance of Eczacibasi should be considered a positive signal. With the involvement of more credible large companies, the weight management category should restore its reputation. The largest domestic pharmaceuticals company, Abdi Ibrahim, on the other hand, expressed no intention in offering a slimming product as it views the market as extremely unstable, dictated by seasonal fashion trends driving demand.

CATEGORY DATA

  • Table 90 Sales of Weight Management: Value 2005-2010
  • Table 91 Sales of Weight Management: % Value Growth 2005-2010
  • Table 92 Weight Management Company Shares 2006-2010
  • Table 93 Weight Management Brand Shares 2007-2010
  • Table 94 Forecast Sales of Weight Management: Value 2010-2015
  • Table 95 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Turkey - Category Analysis

HEADLINES

TRENDS

  • In response to increasing pressure from the pharmacists’ association, the Ministry of Health restricted sales of first aid kits for cars to the chemist/pharmacy channel. The pharmacists’ association had appealed to the Ministry of Health, the Ministry of Interior and TUVTURK (the company undertaking car inspections) for the new legislation, basing its argument on one item, an antiseptic solution, included in the first aid kits. The sale of antiseptic solution itself is only allowed through chemists/pharmacies as it is considered a pharmaceutical product, therefore any item that contains an active pharmaceutical ingredient should also be sold exclusively through chemists/pharmacies. Until the legislation, first aid kits were also available in petrol/gas stations and supermarkets.

COMPETITIVE LANDSCAPE

  • Betasan AS, owned by Münir Sahin Pharmaceutical Company, leads the market with 40% of value sales with a variety of brands including Sanitabant, Betapore, Betaipek and Santavick, and it has recently introduced the Betacure line comprising new products such as hydrocolloid foam backed. The Sanitabant line has also been extended with new products such as gelatine plasters and first aid kits. Sanitabant is the most established brand in the market, with a widespread presence across many retail points.

PROSPECTS

  • The wound care category is expected to decline by 9% in constant value terms over the forecast period. Since there are no prescription products available in this category, it will not be influenced by the proposed OTC legislation. As the category was unprepared for this legislation, introduction of new first aid kit products has been delayed. Just as Sanitabant introduced its first aid kits, other existing companies and new players are expected to follow.

CATEGORY DATA

  • Table 96 Sales of Wound Care by Category: Value 2005-2010
  • Table 97 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 98 Wound Care Company Shares by Value 2006-2010
  • Table 99 Wound Care Brand Shares by Value 2007-2010
  • Table 100 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 101 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Isoflavones
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
        • Tonics and Bottled Nutritive Drinks
        • Vitamins
          • Multivitamins
          • Single Vitamins
            • Vitamin A
            • Vitamin B
            • Vitamin C
            • Vitamin D
            • Vitamin E
            • Other Single Vitamins
      • Weight Management
        • Meal Replacement Slimming
        • OTC Obesity
        • Slimming Teas
        • Weight Loss Supplements
        • Other Slimming Products
      • Herbal/Traditional Products
        • Herbal/Traditional Analgesics
        • Herbal/Traditional Calming and Sleeping Products
        • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
        • Herbal/Traditional Digestive Remedies
        • Herbal/Traditional Medicated Skin Care
        • Herbal/Traditional Medicinal Teas
        • Herbal/Traditional Smoking Cessation Aids
        • Herbal/Traditional Child-Specific Dietary Supplements
        • Herbal/Traditional Dietary Supplements
        • Herbal/Traditional Tonics and Bottled Nutritive Drinks
      • Allergy Care
        • Allergy Eye Care
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Allergy Remedies
        • Topical Allergy Remedies/Antihistamines
      • Child-Specific Consumer Health
        • Child-Specific Analgesics
          • Child-Specific Acetaminophen
          • Child-Specific Aspirin
          • Child-Specific Combination Products - Analgesics
          • Child-Specific Diclofenac
          • Child-Specific Dipyrone
          • Child-Specific Ibuprofen
          • Child-Specific Ketoprofen
          • Child-Specific Naproxen
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Child-Specific Medicated Skin Care
        • Nappy (Diaper) Rash Treatments
        • Child-Specific Vitamins and Dietary Supplements

    Statistics Included

    Statistics Included

    For each category and subcategory you will receive the following data in Excel format:

    From Passport

    • Market sizes
    • Company shares
    • Brand shares
    • Distribution
    • Analysis by format
    • Analysis by positioning
    • Analysis by type
    • Herbal/traditional vs standard
    • Pricing
    • Smoking population - number of adult smokers
    • Smoking prevalence - % of adult population

    Market size details:

    • Retail volume
    • Retail volume % growth
    • Retail volume per capita
    • Retail value retail selling price % growth
    • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices % growth
    • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price % growth
    • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices % growth
    • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices % growth
    • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices % growth
    • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

    Methodology

    Methodology

    Global insight and local knowledge

    With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

    This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

    Industry specialists

    Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

    Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

    The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

    Country and regional analysts

    Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

    In-country research network

    To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

    Research Methodology

    Our research methods

    Each Euromonitor International industry report is based on a core set of research techniques:

    Desk research

    With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

    • National statistics offices governmental and official sources
    • National and international trade press
    • National and international trade associations
    • Industry study groups and other semi-official sources
    • Company financials and annual reports
    • Broker reports
    • Online databases
    • The financial, business and mainstream press

    Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

    Store checks

    Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

    • Place: We track products in all relevant channels, selective and mass, store and non-store
    • Product: What are innovations in products, pack sizes and formats?
    • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
    • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

    Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

    Trade survey

    Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

    Trade surveys allow us to:

    • Fill gaps in available published data per company
    • Generate a consensus view of the size, structure and strategic direction of the category
    • Access year-in-progress data where published sources are out of date
    • Evaluate the experts’ views on current trends and market developments

    In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

    Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

    Company analysis

    At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

    At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

    Forecasts

    Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

    Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

    Data validation

    All data is subjected to an exhaustive review process, at country, regional and global levels.

    The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

    Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

    Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

    Market analysis

    Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

    Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

    my pages

    Want to find out more about this report?

    RELATED

    Country Report

    Consumer Lifestyle

    Country Report

    Future Demographic